Cite
Recurrent FXYD2 p.Gly41Arg mutation in patients with isolated dominant hypomagnesaemia
MLA
Michelle Muller, et al. Recurrent FXYD2 p.Gly41Arg Mutation in Patients with Isolated Dominant Hypomagnesaemia. Jan. 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....684317e1b7ed13588743c2fb00e0005f&authtype=sso&custid=ns315887.
APA
Michelle Muller, Eiske M. Dorresteijn, Marinus A. van den Dorpel, Jeroen H. F. de Baaij, Nine V A M Knoers, Joost G. J. Hoenderop, René J. M. Bindels, Eric A. M. Hennekam, Olivier Devuyst, Erik-Jan Kamsteeg, Rowdy Meijer, & Karin Dahan. (2015). Recurrent FXYD2 p.Gly41Arg mutation in patients with isolated dominant hypomagnesaemia.
Chicago
Michelle Muller, Eiske M. Dorresteijn, Marinus A. van den Dorpel, Jeroen H. F. de Baaij, Nine V A M Knoers, Joost G. J. Hoenderop, René J. M. Bindels, et al. 2015. “Recurrent FXYD2 p.Gly41Arg Mutation in Patients with Isolated Dominant Hypomagnesaemia,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....684317e1b7ed13588743c2fb00e0005f&authtype=sso&custid=ns315887.